EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+15.98%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$142M
AUM Growth
+$142M
(+12%)
Cap. Flow
-$54.9K
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
49.55%
Holding
52
New
6
Increased
14
Reduced
22
Closed
7
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$2.8M |
| 2 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$2.44M |
| 3 |
argenx
ARGX
|
$2.35M |
| 4 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$2.31M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$2.14M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$2.33M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.98M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$1.84M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$1.76M |
| 5 |
Armstrong World Industries
AWI
|
$1.66M |
Sector Composition
| 1 | Healthcare | 52.79% |
| 2 | Financials | 31.36% |
| 3 | Consumer Discretionary | 8.42% |
| 4 | Industrials | 2.47% |
| 5 | Technology | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Madrigal Pharmaceuticals
MDGL
$9.7B
| $2.21M | 1.55% |
17,632
+594
| +3% | +$74.4K |
|
27
Iovance Biotherapeutics
IOVA
$800M
| $2.2M | 1.54% |
230,892
-16,750
| -7% | -$159K |
|
28
Rhythm Pharmaceuticals
RYTM
$6.75B
| $2.18M | 1.53% |
79,398
-3,369
| -4% | -$92.3K |
|
29
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.16M | 1.52% |
265,013
-52,732
| -17% | -$429K |
|
|
ARNA
30
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.14M | 1.51% |
+47,779
| New | +$2.14M |
|
31
Heron Therapeutics
HRTX
$204M
| $2.11M | 1.49% |
86,477
+2,212
| +3% | +$54K |
|
32
Seagate
STX
$37.5B
| $2.02M | 1.42% |
42,219
-1,444
| -3% | -$69.2K |
|
|
GHDX
33
DELISTED
Genomic Health, Inc.
GHDX
| $2.01M | 1.41% |
28,619
-1,700
| -6% | -$119K |
|
34
Bread Financial
BFH
$3.07B
| $1.95M | 1.37% |
11,142
+1,633
| +17% | +$286K |
|
35
Morgan Stanley
MS
$237B
| $1.94M | 1.36% |
45,964
+3,221
| +8% | +$136K |
|
36
KKR & Co
KKR
$120B
| $1.93M | 1.35% |
82,041
-3,900
| -5% | -$91.6K |
|
37
CBRE Group
CBRE
$47.3B
| $1.91M | 1.34% |
38,566
-4,966
| -11% | -$246K |
|
38
Arcosa
ACA
$4.69B
| $1.87M | 1.32% |
+61,342
| New | +$1.87M |
|
39
Bausch Health
BHC
$2.72B
| $1.87M | 1.32% |
75,828
+2,299
| +3% | +$56.8K |
|
40
Citigroup
C
$175B
| $1.87M | 1.31% |
30,027
+932
| +3% | +$58K |
|
41
SLM Corp
SLM
$6.44B
| $1.69M | 1.18% |
170,029
-9,104
| -5% | -$90.2K |
|
42
Trinity Industries
TRN
$2.25B
| $1.65M | 1.16% |
75,769
-5,970
| -7% | -$130K |
|
|
SMC
43
Summit Midstream Corporation
SMC
$272M
| $852K | 0.6% |
87,560
| – | – |
|
44
Cocrystal Pharma
COCP
$15M
| $417K | 0.29% |
152,916
| – | – |
|
45
SPDR S&P 500 ETF Trust
SPY
$656B
| $266K | 0.19% |
942
+70
| +8% | +$19.8K |
|
|
46
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
-31,959
| Closed | -$2.33M |
|
47
Amazon
AMZN
$2.41T
| – | – |
-158
| Closed | -$237K |
|
|
48
Armstrong World Industries
AWI
$8.42B
| – | – |
-28,514
| Closed | -$1.66M |
|
|
DRNA
49
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-172,524
| Closed | -$1.84M |
|
|
XLRN
50
DELISTED
Acceleron Pharma Inc.
XLRN
| – | – |
-45,445
| Closed | -$1.98M |
|